I am/have/had
I am looking for
Advanced Filters
Found 242 clinical trials
The Effect of Hepatic Impairment on Aprocitentan Pharmacokinetics
This is a prospective, single-center, open-label, single-dose, Phase 1 study, to assess the effect of moderate hepatic impairment due to liver cirrhosis on the pharmacokinetics of aprocitentan (ACT-132577).
moderate hepatic impairment
hepatic impairment
hysterectomy
kidney function tests
diastolic blood pressure
- 0 views
- 16 Feb, 2024
- 1 location
A Study of Oral Tazemetostat in Subjects With Moderate and Severe Hepatic Impairment With Advanced Malignancies
This is a phase 1, 2-part, global, multicenter, open-label, PK, safety and tolerability study of oral tazemetostat in subjects with either advanced solid tumors, or hematological malignancies and normal hepatic function or moderate, or severe hepatic impairment.
b-cell lymphoma
progesterone
solid tumors
hepatic impairment
tazemetostat
- 0 views
- 16 Feb, 2024
- 5 locations